| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wiggans Thomas G is a Director at JSPR. Recent filings cover 6 purchases and 0 sales. Those positions are worth an estimated $100K at current prices.
Our model assigns Wiggans Thomas G a strong insider score of 89/100, based on 6 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +100.0%.
Wiggans Thomas G's largest disclosed position is in JSPR as Director, worth about $100K. Net of sales, the recent Form 4 record there shows accumulation of 91,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | Director | Buy | 41,000 | $2.43 | $99,630.00 | New | -24.8% | -75.5% | |
| Nov 28, 2023 | JSPR Jasper Therapeutics, Inc. | Director | Buy | 10,000 | $0.65 | $6,486.00 | +25.0% | +220.0% | +257.6% | |
| Nov 21, 2023 | JSPR Jasper Therapeutics, Inc. | Director | Buy | 10,000 | $0.64 | $6,383.00 | +33.3% | +203.3% | +227.3% | |
| Nov 20, 2023 | JSPR Jasper Therapeutics, Inc. | Director | Buy | 30,000 | $0.61 | $18,240.00 | New | +203.3% | +222.8% |